Capcium

Capcium

closed
A privately-owned Montreal-based global leader in softgel manufacturing. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD62—93m (Dealroom.co estimates Jun 2018.)
St. Louis Missouri (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

$10.0m

Early VC
Total FundingAUD15.5m

Recent News about Capcium

Edit
More about Capciuminfo icon
Edit

Capcium is a Canadian company specializing in the manufacturing of high-quality softgel capsules. Serving clients in the pharmaceutical, nutraceutical, cosmetic, and cannabis sectors, Capcium provides a comprehensive range of encapsulation services. The company operates in a highly specialized market, offering precision-focused, pharmaceutical-grade manufacturing that meets the specific needs of its diverse clientele. Capcium's business model revolves around contract manufacturing, where they produce softgel capsules for other companies, ensuring consistent quality and dosage. Their revenue is generated through these manufacturing contracts, which include formulation and process development services. Capcium's expertise in encapsulation technology allows them to help clients bring their products to market quickly and efficiently. The company is known for its exacting standards and ability to open new market opportunities for its clients by transforming their molecules into effective softgel formats.

Keywords: softgel capsules, pharmaceutical, nutraceutical, cosmetic, cannabis, encapsulation, contract manufacturing, formulation, process development, precision-focused.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.